EDGAR Filing Documents for 0001564590-17-004469

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001564590-17-004469

Filing Date

2017-03-15

Accepted

2017-03-15 17:24:35

Documents

Effectiveness Date

2017-03-15

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	aimt-s8.htm	S-8	132413
2	EX-5.1	aimt-ex51_20.htm	EX-5.1	17997
3	EX-23	aimt-ex23_21.htm	EX-23	2218
4	GRAPHIC	g2017031422472941837332.jpg	GRAPHIC	2412
5	GRAPHIC	g2017031422472947737333.jpg	GRAPHIC	58309
	Complete submission text file	0001564590-17-004469.txt		237656

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884

Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220

Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-216724 | Film No.: 17692171
SIC: 2834 Pharmaceutical Preparations